TripTonic – Magic Mushroom Micro Pills – Blue Meanies
TripTonic – Magic Mushroom Micro Pills – Blue Meanies offer a standardized and reliable way to experience the benefits of psilocybin in a controlled microdose format. Each capsule contains 200mg of high-quality, lab-tested psilocybin derived from Psilocybe cubensis mushrooms, prepared to ensure consistency, purity, and safety. Ideal for individuals seeking cognitive clarity, mood enhancement, or wellness support, without the intensity of a full psychedelic experience.
This 10-capsule pack is designed for structured microdosing routines, with each capsule offering a low, sub-perceptual dose to support daily function. Capsules are vegan, easy to swallow, and also produced in accordance with current health and safety standards.
Blue Meanies
Blue Meanies, a potent and highly regarded strain of Psilocybe cubensis. Known for its rich psilocybin content, Blue Meanies offer a more refined and energizing microdose experience. Users often report enhanced mental clarity, uplifted mood, and a deeper sense of connection. This strain is valued for its clean, consistent effects and is a preferred choice among experienced microdosers.
Instructions & Guidelines for Use – TripTonic Micro Pills (200mg)
- Recommended Use: Take 1 capsule (200mg) every 3rd day (e.g., Monday, Thursday, Sunday). Daily use is not recommended.
- Timing: For best results, take in the morning on an empty stomach.
- Duration: Use for a period of 4 to 8 weeks, followed by at least 2 weeks off to reset tolerance.
Important Guidelines:
- Do not drive or operate heavy machinery on dosing days.
- Avoid alcohol or other substances while using this product.
- Effects may vary, start with one capsule to assess personal sensitivity.
- Consult a healthcare provider before use, especially if pregnant, nursing, or taking medication.
- Not intended to treat or cure any medical conditions.
Please consult a healthcare provider before use. Store in a cool, dry place, out of reach of children.
Reviews
There are no reviews yet.